About Viz.ai
Viz.ai is a company based in San Francisco (United States) founded in 2016 by Chris Mansi and David Golan. Viz.ai has raised $251.99 million across 7 funding rounds from investors including Canadian Imperial Bank of Commerce, Kleiner Perkins and Seedcamp. Viz.ai offers products and services including Viz.ai One, Viz Neuro Suite, Viz Vascular Suite, Viz Cardio Suite, and Viz Radiology Suite. Viz.ai operates in a competitive market with competitors including AIdoc, PathAI, Perspectum, Deepcell and Qure.ai, among others.
- Headquarter San Francisco, United States
- Founders Chris Mansi, David Golan
- Stage Unicorn
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Viz.Ai
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$251.99 M (USD)
in 7 rounds
-
Latest Funding Round
$40 M (USD), Debt – Conventional
Mar 22, 2023
-
Investors
Canadian Imperial Bank of Commerce
& 15 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Viz.ai
Viz.ai offers a comprehensive portfolio of products and services, including Viz.ai One, Viz Neuro Suite, Viz Vascular Suite, Viz Cardio Suite, and Viz Radiology Suite.
AI solution for detecting and coordinating treatments across diseases.
AI tools for identifying strokes and aneurysms in medical imaging.
Platform for pulmonary embolism and aortic disease analysis.
AI for hypertrophic cardiomyopathy and post-stroke care.
AI to accelerate diagnosis in radiology workflows.
People of Viz.ai
Unlock access to complete
Unlock access to complete
Leadership Team
16 people
Human Resources and Administration
9 people
Senior Team
6 people
Software Development Team
6 people
Data Analysis and Operations Team
5 people
Clinical Team
4 people
Board Team
4 people
Sales and Marketing
3 people
Unlock access to complete
Funding Insights of Viz.ai
Viz.ai has successfully raised a total of $251.99M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $40 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Viz.ai
Viz.ai has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include Canadian Imperial Bank of Commerce, Kleiner Perkins and Seedcamp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture and private equity investments are managed with global diversification.
|
Locked | Locked | Locked | |
|
Investment firm scaling software and technology companies from early to late stages.
|
Locked | Locked | Locked | |
|
Early-stage venture capital investments are focused on US companies.
|
Locked | Locked | Locked |
Investor details for Viz.ai
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Viz.ai
Investment portfolio details for Viz.ai
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Viz.ai
Detailed financials for Viz.ai
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Viz.Ai Comparisons
Peer comparison for Viz.ai
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Viz.ai
Viz.ai operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AIdoc, PathAI, Perspectum, Deepcell and Qure.ai, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
AI-powered solutions for medical imaging diagnostics
|
Detailed competitors of Viz.ai
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Viz.Ai
Complete news archive for Viz.ai
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Viz.ai
Viz.ai was founded in 2016.
Viz.ai is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Chris Mansi is the current CEO of Viz.ai. They have also founded this company.
Viz.ai is a funded company, having raised a total of $251.99M across 7 funding rounds to date.
Viz.ai was founded in 2016 in San Francisco, United States, within the healthcare technology sector. AI-driven care coordination software is provided for stroke diagnosis and neurology support. Emergency medical cases are addressed through tools that compare patient scans to databases, identifying patterns for conditions. Scans are categorized into types to aid clinical decisions, with operations centered on cloud-based platforms.
Viz.ai's top competitors include Perspectum, Qure.ai and AIdoc.
Viz.ai offers Viz.ai One, Viz Neuro Suite, Viz Vascular Suite, Viz Cardio Suite, and Viz Radiology Suite.
Viz.ai has 16 investors. Key investors include Canadian Imperial Bank of Commerce, Kleiner Perkins, Seedcamp, Pear VC, and Tiger Global.
The valuation of Viz.ai is $1.2B as of Apr 2022.